SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-117977
Filing Date
2024-04-26
Accepted
2024-04-26 16:06:02
Documents
9
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d697760ddef14a.htm DEF 14A 391902
2 GRAPHIC g697760dsp36.jpg GRAPHIC 131008
3 GRAPHIC g697760dsp36a.jpg GRAPHIC 3949
4 GRAPHIC g697760dsp36b.jpg GRAPHIC 3561
5 GRAPHIC g697760dsp36d.jpg GRAPHIC 3211
6 GRAPHIC g697760dsp37.jpg GRAPHIC 16315
7 GRAPHIC g697760dsp37a.jpg GRAPHIC 1474
8 GRAPHIC g697760g10g00.jpg GRAPHIC 38110
9 GRAPHIC g697760g88z25.jpg GRAPHIC 38110
  Complete submission text file 0001193125-24-117977.txt   711052
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40602 | Film No.: 24883596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)